Gruppo Italiano Malattie EMatologiche dell'Adulto: Purpura, Thrombocytopenic, Idiopathic trials
The registry lists 10 Purpura, Thrombocytopenic, Idiopathic studies with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010Not yet recruitingNCT06466824
- Biologic Characterization of Patients With ITPRecruitingNCT05694325Not applicable
- Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITPCompletedNCT05613296
- Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITPStatus unknownNCT04735588
- Investigation on a Dynamic Cohort of Italian Patients With Active ITPStatus unknownNCT03465020
- Eltrombopag in Second Line Adult Primary Immune ThrombosytopeniaCompletedNCT02402998Phase 2
- Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune ThrombocytopeniaCompletedNCT02298075
- TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.CompletedNCT02063763
- Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)CompletedNCT01510873
- Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic PurpuraCompletedNCT00657410Phase 3